you are here:

Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals

BSE Live

Apr 09, 16:00
636.95 22.65 (3.69%)
Volume
AVERAGE VOLUME
5-Day
396,190
10-Day
268,679
30-Day
311,711
886,467
  • Prev. Close

    614.30

  • Open Price

    615.00

  • Bid Price (Qty.)

    636.95 (50)

  • Offer Price (Qty.)

    636.95 (695)

NSE Live

Apr 09, 15:59
636.75 22.50 (3.66%)
Volume
AVERAGE VOLUME
5-Day
7,506,826
10-Day
6,394,829
30-Day
6,307,160
16,755,446
  • Prev. Close

    614.25

  • Open Price

    613.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    636.75 (2197)

Financials

2020 2019 2018 2017 2016
Quarterly Results of Sun Pharmaceutical Industries (in Rs. Cr.) Dec '20 Sep '20 Jun '20 Mar '20 Dec '19  
Net Sales/Income from operations 3,366.01 3,207.24 2,878.64 2,750.41 2,920.83  
Other Operating Income 22.01 85.27 84.40 85.67 92.72  
Total Income From Operations 3,388.02 3,292.51 2,963.04 2,836.08 3,013.55  
EXPENDITURE  
Consumption of Raw Materials 832.81 1,002.72 849.42 767.12 947.21  
Purchase of Traded Goods 303.52 269.73 257.82 318.88 303.12  
Increase/Decrease in Stocks 206.18 -95.47 -55.29 94.28 -145.17  
Power & Fuel -- -- -- -- --  
Employees Cost 455.48 452.16 466.19 419.34 423.97  
depreciat 146.89 145.37 142.79 142.44 144.40  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 843.79 875.88 722.88 1,007.92 778.61  
P/L Before Other Inc. , Int., Excpt. Items & Tax 599.35 642.12 579.23 86.10 561.41  
Other Income 20.98 73.18 21.19 1,218.65 15.36  
P/L Before Int., Excpt. Items & Tax 620.33 715.30 600.42 1,304.75 576.77  
Interest 71.93 13.42 68.90 137.53 98.76  
P/L Before Exceptional Items & Tax 548.40 701.88 531.52 1,167.22 478.01  
Exceptional Items -- -- -- -- --  
P/L Before Tax 548.40 701.88 531.52 1,167.22 478.01  
Tax -7.15 -22.93 -0.43 11.37 9.25  
P/L After Tax from Ordinary Activities 555.55 724.81 531.95 1,155.85 468.76  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 555.55 724.81 531.95 1,155.85 468.76  
Equity Share Capital 239.93 239.93 239.93 239.93 239.93  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 2.32 3.02 2.22 4.82 1.95  
Diluted EPS 2.32 3.02 2.22 4.82 1.95  
EPS After Extra Ordinary  
Basic EPS. 2.32 3.02 2.22 4.82 1.95  
Diluted EPS. 2.32 3.02 2.22 4.82 1.95  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited